Report overview
Sinusitis, also known as a sinus infection or rhinosinusitis, is inflammation of the sinuses resulting in symptoms. Common signs and symptoms include thick nasal mucus, a plugged nose, and pain in the face. Other signs and symptoms may include fever, headaches, poor sense of smell, sore throat, and cough. The cough is often worse at night. Serious complications are rare. It is defined as acute rhinosinusitis (ARS) if it lasts less than 4 weeks, and chronic rhinosinusitis (CRS) if it lasts for more than 12 weeks. Drugs for Sinusitis are common in the market, and the drugs can also be used in other disease. These drugs can not cure sinusitis, can only relieve symptoms.
This report aims to provide a comprehensive presentation of the global market for Sinusitis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sinusitis Drugs. This report contains market size and forecasts of Sinusitis Drugs in global, including the following market information:
Global Sinusitis Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Sinusitis Drugs market was valued at US$ 2300.7 million in 2022 and is projected to reach US$ 2878.8 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Drugs For Sinusitis key players include Sanofi, Bayer AG, Pfizer, AstraZeneca Plc, etc. Global top four manufacturers hold a share over 30%.
North America is the largest market, with a share about 35%, followed by Europe, and Asia (Ex.China), both have a share over 40 percent.
In terms of product, Corticosteroids is the largest segment, with a share about 30%. And in terms of application, the largest application is Acute Sinusitis, followed by Acute Sinusitis.
We surveyed the Sinusitis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sinusitis Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Sinusitis Drugs Market Segment Percentages, by Type, 2022 (%)
Analgesics
Antihistamines
Corticosteroids
Antibiotics
Sulphonamides
Global Sinusitis Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Sinusitis Drugs Market Segment Percentages, by Application, 2022 (%)
Acute Sinusitis
Chronic Sinusitis
Global Sinusitis Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Sinusitis Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sinusitis Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Sinusitis Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Bayer
Pfizer
AstraZeneca
Novartis
Johnson & Johnson
Merck
Amgen
Teva Pharmaceutical
Fresenius Kabi
Bionorica
Dr. Reddy's Laboratories
Sun Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Sinusitis Drugs, market overview.
Chapter 2: Global Sinusitis Drugs market size in revenue.
Chapter 3: Detailed analysis of Sinusitis Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sinusitis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.